[Some HBeAg-negative chronic hepatitis B patients treated with nucleos(t)ide analogue can achieve HBsAg loss after drug withdrawal: stop-to-cure may be coming].
Zhonghua Yi Xue Za Zhi
; 102(40): 3160-3166, 2022 Nov 01.
Article
in Zh
| MEDLINE
| ID: mdl-36319170
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hepatitis B, Chronic
/
Hepatitis B Surface Antigens
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
Zh
Journal:
Zhonghua Yi Xue Za Zhi
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: